Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023
Clinical and Experimental Nephrology · 2024-06 · 28 (6) · 473-495
DOI: 10.1007/s10157-024-02497-4 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 07.05.2024. Verfasst von Japanese Society of Nephrology. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Evidence-Based Medicine. Die Arbeit wurde bisher 82-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Japanese Society of Nephrology (2024). Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clinical and Experimental Nephrology, 28(6), 473-495. https://doi.org/10.1007/s10157-024-02497-4
Vancouver
Japanese Society of Nephrology. Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023. Clinical and Experimental Nephrology. 2024;28(6):473-495. doi:10.1007/s10157-024-02497-4
BibTeX
@article{JapaneseSocietyofNephrology2024,
author = {Japanese Society of Nephrology, Japanese Society of Nephrology},
title = {Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023},
journal = {Clinical and Experimental Nephrology},
year = {2024},
volume = {28},
number = {6},
pages = {473--495},
doi = {10.1007/s10157-024-02497-4}
}
EUVIMED